Deepa is Chief Financial Officer of Secretome Therapeutics. Deepa brings over 20 years of healthcare experience spanning operations, venture capital, and investment banking. She currently sits on the Board of Design Therapeutics (Nasdaq: DSGN) and is Executive Director of the Robinson Life Science and Entrepreneurship Program at UC Berkeley. She is also a Strategic Advisor to several healthcare companies.

She most recently served as President/CEO and Board Member of vTv Therapeutics (Nasdaq: VTVT).  Previous to vTv, she was General Partner at WestRiver Group where she led the Healthcare Innovation Fund's investments in Design Therapeutics (Nasdaq: DSGN), Ginger (now $3B Headspace Health), and Curai. She sat on the Boards of Lumen Bioscience and Viome. In June 2021, Deepa was the recipient of the "General Partners Rising Star Award" by Falk Marques Group sponsored by Deloitte.

Deepa’s other roles included Chief of Staff at Blue Shield, Regional VP for Optum (NYSE: UNH), VP of Financial Strategy and Business Development at Coherus Biosciences (Nasdaq: CHRS) and a decade in biotech investment banking executing private placements and buyside/sellside M&A for biotech and pharma companies.